The Role of EU HTA in National Healthcare: Bridging policy and patient access webinar

The Webinar:  

This webinar explored how Health Technology Assessment (HTA) served as a vital link between policy development and patient access to innovative healthcare solutions. Bringing together patient organisations, policymakers, HTA bodies, healthcare professionals, and industry representatives, the event focused on how HTA processes could be optimised to better reflect patient needs and support equitable access to high-quality care.

Through best-practice presentations and a panel discussion, the webinar highlighted current challenges and actionable strategies to ensure that HTA contributed meaningfully to healthcare decision-making and patient outcomes.

Overall Goal:  

The goal of this webinar was to foster a more inclusive and transparent HTA landscape that effectively integrated patient perspectives and supported timely access to innovation. By facilitating dialogue among key stakeholders, the event aimed to strengthen the role of HTA in advancing patient-centred healthcare policy at national and regional levels.

Programme:

Opening and Welcome

• Moderator: Maria Luisa Pagano, Pancreatic Cancer Europe (PCE), Secretariat Coordinator, Belgium

• Jacqueline Daly, Cancer Patients Europe (CPE), Vice-Chair of the Board, Belgium

• Maya Matthews, Chair of the HTA Stakeholder Network, Directorate-General for Health and Food Safety, European Commission:
  State of play of the HTA regulation and the involvement of patients and clinicians

• Tomislav Sokol, MEP, Committee on Public Health (SANT):
  How other EU legislations such as European Health Data Space and General Pharmaceutical Legislation can help accelerate the implementation of the EU HTA Regulation

Panel Discussion: Patient involvement in the HTA to accelerate access to innovative treatments

• Moderator: Josephine Mosset, Cancer Patients Europe (CPE), Senior Policy Officer, Belgium

• Valentina Stramiello, European Patients Forum, Belgium: HTA Multistakeholder network or training for patients
• Marcus Guardian, Brussels Centre for Collaboration in Health, Belgium: How BCCH is facilitating the involvement of patients in JCA
• Frederick Martinez, Cancer Patients Europe (CPE) Junior Policy Officer, Belgium: The involvement of patients in JCA
• Alessandra Lo Scalzo, Agenzia Nazionale per i Servizi Sanitari Regionali (AGENAS), Italy: Italy’s Approach to Patient Involvement in HTA
• Iga Rawicka, EuropaColon Poland, Poland: The experience of the patient association in the HTA national process
• Susanne Teupen, Unit Patient Participation, G-BA, Germany: How the HTA in Germany is preparing for patient involvement
• Daniel Cairns, Scottish Medicines Consortium (SMC), UK: The simplified information paper (SIP)

Q&A

Conclusions and Final Remarks

• Alfredo Carrato, PCE Chair of the Board of Directors, Belgium

Closing of the Event

Stay Connected

Follow PCE on X, Facebook, LinkedIn, Instagram, Threads & BlueSky

PCE YouTube Channel